AGM, EGM, Placing, Joint Broker Appointment

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in the Republic of Ireland), Canada, Australia, Japan or the Republic of South Africa.

17 February 2021

Chrysalis Investments Limited (the "Company")

Notice of AGM and Notice of EGM

Placing Programme and Appointment of Joint Broker

The Company is pleased to confirm that it will shortly be posting its notice of Annual General Meeting ("AGM") to Shareholders. The AGM will be held at 3rd Floor, 1 Le Truchot, St Peter Port, Guernsey GY1 1WD on 8 March 2021 at 09:00 am.

In addition, the Company will also be posting a circular and notice of an extraordinary general meeting ("EGM") which will be held on the same day and the same venue as the AGM at 09:30 am, or, if later, as soon as possible after the AGM shall have been concluded or adjourned (the AGM and EGM together being the "Meetings").

The business of the EGM is to seek shareholder authority to issue up to 600 million ordinary and/or C shares without regard to the pre-emption rights set out in the Company's articles in respect of a proposed placing programme (the "Placing Programme"). The Company intends to publish a prospectus in March 2021 giving further information about the Placing Programme.

The AGM and EGM notices, together with accompanying proxy-voting forms, will be submitted to the National Storage Mechanism today and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and will also be available on request from the Company at its registered office and on the Company's website at http://chrysalisinvestments.co.uk.

Rationale for the Placing Programme

At the time of the Company's IPO in November 2018, the Company put in place a placing programme. Since that time, the Company has undertaken a number of capital raises utilising that programme authority at a premium to prevailing NAV per share. The Company has successfully invested the proceeds of each capital raise in a timely manner which has allowed it to add compelling new investments to its portfolio, helping to drive value and increase diversification, as well as enabling it to pursue follow-on opportunities which have underpinned its strong overall portfolio performance.

Merian Global Investors (UK) Limited, the Company's Investment Adviser, has a strong pipeline of investment opportunities totaling ca.£1 billion and has identified potential follow-on opportunities of up to ca. £250m that may be available over the coming months. Accordingly, the Board believes that seeking approval of the new Placing Programme to enable the Company to raise further capital will put it in a strong position to take advantage of the compelling pipeline and available follow-on opportunities. 

Joint Broker Appointment

The Company is pleased to announce the appointment of Numis Securities Limited as joint Corporate Broker with immediate effect, working alongside the Company's existing Corporate Broker, Liberum Capital Limited.

-ENDS-

LEI: 213800F9SQ753JQHSW24

IMPORTANT INFORMATION

A copy of this announcement will be available on the Company's website at http://chrysalisinvestments.co.uk. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk.  Past performance is no guarantee of future returns.  Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision.  The value of investments may fluctuate.  Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company. 

Recipients of this announcement who are considering acquiring shares following publication of the prospectus are reminded that any such acquisition must be made only on the basis of the information contained in the prospectus which may be different from the information contained in this announcement. The subscription for shares is subject to specific legal or regulatory restrictions in certain jurisdictions. Persons distributing this announcement must satisfy themselves that it is lawful to do so. The Company assumes no responsibility in the event that there is a violation by any person of such restrictions.

This announcement may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States. This document does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States. The securities mentioned herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended or with any securities regulatory authority of any state or other jurisdiction of the United States. The Company has not been, and will not be, registered under the U.S. Investment Company Act of 1940, as amended.

Neither this announcement nor any copy of it may be: (i) taken or transmitted into or distributed in any member state of the European Economic Area (other than to professional investors in the Republic of Ireland), Canada, Australia, Japan or the Republic of South Africa or to any resident thereof, or (ii) taken or transmitted into or distributed in Japan or to any resident thereof. Any failure to comply with these restrictions may constitute a violation of the securities laws or the laws of any such jurisdiction. The distribution of this announcement in other jurisdictions may be restricted by law and the persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.

COVID-19 Pandemic

The Company is continuing to monitor developments relating to the Covid-19 pandemic, including legislation issued by the UK and Guernsey governments and the related public health guidance. As the Company prioritises the health and wellbeing of all stakeholders, the Company will make the necessary arrangements such that the legal requirements to hold the meeting are satisfied through the attendance of the minimum number of members present in person or by proxy in order to ensure a quorate meeting. The Board recognise the importance of the Meetings to shareholders and wish to ensure that you are able to exercise your rights to participate in the Meetings through voting. Details of how to submit your proxy vote by post, by email or through CREST are set out in the Circular.

Under the current travel restrictions in place in Guernsey we would recommend that Shareholders appoint the Chairman to represent their votes at the respective Meetings. This is an evolving situation therefore, if restrictions change that affect the format of the Meetings the Company will communicate this to shareholders via the Company's website and an RIS announcement.